Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Copenhagen Stock Exchange  >  Novo Nordisk A/S    NOVO.B   DK0060534915

Delayed Quote. Delayed BATS Europe - 08/05 08:16:00 am
408.2 DKK   +0.29%
08/03DJNOVO NORDISK A/ : 2Q 2015 -- Forecast
08/03 NOVO NORDISK A/ : A/S : - Share repurchase programme
07/27 NOVO NORDISK A/ : A/S : - Share repurchase programme
 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Copenhagen Stock Exchange
07/29/2015 07/30/2015 07/31/2015 08/03/2015 08/04/2015 Date
400 397.2 398.4 409.5 407 Last
1936727 2529683 2429438 2356414 2122034 Volume
+1.78% -0.70% +0.30% +2.79% -0.61% Change
Financials ( DKK)
Sales 2015 108 350 M
EBIT 2015 47 792 M
Net income 2015 33 558 M
Finance 2015 10 146 M
Yield 2015 1,47%
Sales 2016 117 550 M
EBIT 2016 51 169 M
Net income 2016 39 495 M
Finance 2016 11 648 M
Yield 2016 1,76%
PER 2015 31,33
PER 2016 26,40
EV / Sales 2015 7,65x
EV / Sales 2016 7,04x
Capitalization 839 464 M
More Financials
Company
Novo Nordisk AS engages in the research, development, manufacture, and marketing of pharmaceutical products.It operates through the Diabetes Care and Biopharmaceuticals segments.The Diabetes Care segment deals with the research, development, manufacture, and marketing of products within the areas... 
Sector
Pharmaceuticals
Calendar
08/06Earnings Release
More about the company
Surperformance© ratings of Novo Nordisk A/S
Trading Rating : Investor Rating :
More Ratings
Latest news on NOVO NORDISK A/S
08/03DJNOVO NORDISK A/S : 2Q 2015 -- Forecast
08/03 NOVO NORDISK A/S : A/S : - Share repurchase programme
08/03 NOVO NORDISK A/S : Share repurchase programme
07/31 NOVO NORDISK A/S : Poorly controlled Type 2 Diabetes is a worldwide problem- Pro..
07/29 NOVO NORDISK A/S : and NBA Legend Dominique Wilkins Launch My Diabetes Dream Tea..
07/27 NOVO NORDISK A/S : A/S : - Share repurchase programme
07/27 NOVO NORDISK A/S : Share repurchase programme
07/25 NOVO NORDISK A/S : appoints new head of IR
More news
Sector news : Pharmaceuticals - NEC
08:05a PERRIGO : beats Street 4Q forecasts
06:02a EUROPA-MERGERS : Commission approves acquisition of Hospira by Pfizer, subject t..
05:35a ASTRAZENECA : MedImmune Enters Collaboration With Mirati Therapeutics
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
07/31 Vivus Reports Q2 Loss- Confirms Obesity Sector Weakness
07/31 Tracking Ken Fisher's Fisher Asset Management Portfolio - Q2 2015 Update
07/30 Top 3 iShares ETFs Provide Exposure To The Health Care Sector
07/30 ANOTHER HOT BIOPHARMA IPO : vTv Therapeutics
07/29 PREMARKET BIOTECH DIGEST : Merck Earnings, Gilead Beats Again, NantKwest Surges


Comments 
Advertisement
Chart NOVO NORDISK A/S
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO.B | DK0060534915 | 4-Traders
Full-screen chart
Technical analysis trends NOVO NORDISK A/S
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions